Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis

BACKGROUND AND AIMS: Mucosal healing is an important therapeutic goal for ulcerative colitis. Once-daily administration of budesonide 2-mg foam is widely used for inducing clinical remission. No study has assessed the usefulness of twice-daily budesonide 2mg foam on mucosal healing in ulcerative col...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Crohns Colitis
Autors principals: Naganuma, Makoto, Aoyama, Nobuo, Suzuki, Yasuo, Nishino, Haruo, Kobayashi, Kiyonori, Hirai, Fumihito, Watanabe, Kenji, Hibi, Toshifumi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4955911/
https://ncbi.nlm.nih.gov/pubmed/26577683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjv208
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars